- Elevated Plasma Pentraxin 3 and Its Association with Retinal Vein Occlusion
-
Park KS, Kim JW, An JH, Woo JM
- KMID: 2345822
- Korean J Ophthalmol.
- 2014 Dec;28(6):460-465.
- doi: 10.3341/kjo.2014.28.6.460
PURPOSE: To evaluate plasma pentraxin 3 (PTX3) in patients with retinal vein occlusion (RVO), and investigate the possibility of its role as a predictive biomarker. METHODS: Nested case-control study. The study... -
- CITED
-
- Close
- SHARE
-
- Close
- Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells
-
Park SN, Noh KT, Jeong YI, Jung ID, Kang HK, Cha GS, Lee SJ, Seo JK, Kang DH, Hwang TH, Lee EK, Kwon B, Park YM
- KMID: 2154227
- Exp Mol Med.
- 2013 Feb;45(2):e8.
We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin... -
- CITED
-
- Close
- SHARE
-
- Close
